person · Reporting owner
SOBECKI CHRISTOPHER J
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | Director | June 03, 2026 | June 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date June 03, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 293,177 |
Reported balance
After 2026-06-03 transaction · row 1
1 source rowRow 1 · 2026-06-03 · Exercise / conversion · Acquired 89,312 · Balance 293,177 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-06-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-03 · Exercise / conversion · Disposed 89,312 · Balance 0 F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2: Each restricted stock unit represents a contingent right to receive one share of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2: Each restricted stock unit represents a contingent right to receive one share of common stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
WW INTERNATIONAL, INC.
Report date May 31, 2023 · Filed May 31, 2023
Section 16 reporting ended · disclosed 2023-05-31. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 109,954 |
Ending reported balance
After 2023-05-31 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-05-31 · Grant · Acquired 1,353 · Balance 107,901 Row 2 · 2023-05-31 · Exercise / conversion · Acquired 2,053 · Balance 109,954 F1: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-05-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-05-31 · Exercise / conversion · Disposed 2,053 · Balance 0 F1: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. F2: Pursuant to the Reporting Person's election, Deferred Stock Units were settled into shares of Common Stock on May 31, 2023, the date of the Reporting Person's separation from service from the Issuer's Board of Directors, pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement.
F2: Pursuant to the Reporting Person's election, Deferred Stock Units were settled into shares of Common Stock on May 31, 2023, the date of the Reporting Person's separation from service from the Issuer's Board of Directors, pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 200 | $2.27 | $454.00 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,845 Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 21:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 601 | $2.25 | $1,352.25 |
DisclosureSEC source: 0001127602-19-028591 · form4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,645 Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:11 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 989 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-040201 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,464 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| April 26, 2019 Filed Apr 29, 2019 21:02 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 3,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-016491 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,466 Underlying: Common Stock · 3,466 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 26, 2019 Filed Apr 29, 2019 21:02 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 6,519 | $0.00 Strike: $5.67 | $0.00 |
DisclosureSEC source: 0001127602-19-016491 · form4.xml · derivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,519 Underlying: Common Stock · 6,519 shares Expires 2029-04-26 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:34 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 942 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-023149 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,475 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:19 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 453 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-001916 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,533 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 21:07 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GiftCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-060558 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,080 Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:14 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 262 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-053787 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,080 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 20:56 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-049239 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,818 Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:17 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 187 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-041599 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,818 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| April 27, 2018 Filed Apr 27, 2018 21:41 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 2,857 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001127602-18-015454 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,857 Underlying: Common Stock · 2,857 shares Expires 2028-04-27 F1 · derivative.exercise_date: Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant. Read SEC document |
| April 27, 2018 Filed Apr 27, 2018 21:41 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantCommon Stock | 2,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015454 · form4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,044 Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:30 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 295 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023668 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,631 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:22 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 390 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-001952 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,336 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:55 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 435 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-055912 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,946 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| August 07, 2017 Filed Aug 9, 2017 20:20 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 71 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-048247 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director · Former Member, IOCEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,511 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Amount shown represents shares granted as compensation for serving as a Member of the Company's Interim Office of the Chief Executive Officer. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 20:09 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 1,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-043982 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director · Former Member, IOCEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,440 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Amount shown represents 569 shares granted as compensation for serving on the Company's Board of Directors and 910 shares granted as compensation for serving as a Member of the Company's Interim Office of the Chief Executive Officer. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 20:11 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 1,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-038277 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director · Member, Interim Office of CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,961 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Amount shown represents shares granted as compensation for serving as a Member of the Company's Interim Office of the Chief Executive Officer. Read SEC document |
| May 08, 2017 Filed May 10, 2017 20:43 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 1,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031328 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director · Member, Interim Office of CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,842 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Amount shown represents shares granted as compensation for serving as a Member of the Company's Interim Office of the Chief Executive Officer. Read SEC document |
| April 28, 2017 Filed May 1, 2017 20:53 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 2,857 | $0.00 Strike: $15.61 | $0.00 |
DisclosureSEC source: 0001127602-17-016070 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,857 Underlying: Common Stock · 2,857 shares Expires 2027-04-28 F1 · derivative.exercise_date: Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant. Read SEC document |
| April 28, 2017 Filed May 1, 2017 20:53 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantCommon Stock | 1,281 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016070 · form4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,480 Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 20:13 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 3,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-025615 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director · Member, Interim Office of CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,472 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Amount shown represents 1,216 shares granted as compensation for serving on the Company's Board of Directors and 1,946 shares granted as compensation for serving as a Member of the Company's Interim Office of the Chief Executive Officer. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 21:08 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 1,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-019229 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director · Member, Interim Office of CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,310 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Amount shown represents shares granted as compensation for serving as a Member of the Company's Interim Office of the Chief Executive Officer. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 21:20 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 2,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008673 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director · Member, Interim Office of CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,470 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Amount shown represents shares granted as compensation for serving as a Member of the Company's Interim Office of the Chief Executive Officer. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:20 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 11,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002062 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director · Member, Interim Office of CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,035 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Amount shown represents 804 shares granted as compensation for serving on the Company's Board of Directors and 10,358 shares granted as compensation for serving as a Member of the Company's Interim Office of the Chief Executive Officer. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:10 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-155884 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director · Member, Interim Office of CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,873 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:17 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 904 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-144912 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director · Member, Office of the CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,873 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.